Stronger pharma merger control depends on CCI performance
The Government of India wants to encourage foreign direct investment in the country’s pharmaceutical industry, but not to the detriment of domestic players. And while it sees the Competition Commission of India playing a key role in the control of prices, not everyone believes this will be sufficient
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.